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Genome-wide gene expression profile studies encompass increasingly large number of samples, posing a challenge to their pre-
sentation and interpretation without losing the notion that each transcriptome constitutes a complex biological entity. Much like
pathologists who visually analyze information-rich histological sections as a whole, we propose here an integrative approach. We
use a self-organizing maps-based software, the gene expression dynamics inspector (GEDI) to analyze gene expression profiles of
various lung tumors. GEDI allows the comparison of tumor profiles based on direct visual detection of transcriptome patterns.
Such intuitive “gestalt” perception promotes the discovery of interesting relationships in the absence of an existing hypothesis. We
uncovered qualitative relationships between squamous cell tumors, small-cell tumors, and carcinoid tumor that would have es-
caped existing algorithmic classifications. These results suggest that GEDI may be a valuable explorative tool that combines global
and gene-centered analyses of molecular profiles from large-scale microarray experiments.
Copyright © 2006 Yuchun Guo et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
The simultaneous measurement of expression levels of tens
of thousands of genes in a biological sample enabled by DNA
microarray technology has provided a new and powerful way
to characterize the molecular basis of diseases such as cancer
[1, 2]. In the past decade, mRNA expression profiles of tumor
tissues have been successfully used to distinguish tumor types
or subtypes [3–5]. They also appear to hold great promise as
a method for predicting clinical outcomes [6–8]. For exam-
ple, gene expression profiles have been used to classify lung
adenocarcinoma into subgroups that correlated with the de-
gree of tumor differentiation as well as patient survival [9].
Gene expression profile analysis initially emphasized the
identification of groups of genes that are differentially reg-
ulated in different experimental conditions or patient sam-
ples. Coexpression across a variety of samples implied coreg-
ulation or similar function [10, 11]. An approach comple-
mentary to this “gene-centered” view is to take a “sample-
centered” perspective in which one treats the genome-wide
profiles of each sample as the entities to be classified with
respect to their gene expression patterns. The goal here is
to assign samples (rather than genes) to groups based on
the high-dimensional molecular signature determined by the
thousands of individual gene expression values. While the
gene-centered perspective is useful for understanding the
molecular pathways in which individual genes are involved,
the sample-centered view is more relevant for biological and
clinical questions, such as in the study of the developmen-
tal and pathogenetic relationship between tissues as a whole
[12, 13] or the identification of prognostic or diagnostic sig-
natures of tumors based on entire gene expression profile
portraits [4, 14–19].
The notion of “molecular portraits” has gained impor-
tance as gene expression profiles for increasingly large num-
bers of samples or conditions (eg, experimental variables, pa-
tients, treatment groups, etc) have become available [18, 20,
21]. However, the analysis of large numbers of gene expres-
sion profiles as integrated entities poses a challenge in terms
of how to best organize and graphically present the high-
dimensional data without loss of the notion of an individ-
ual profile as an independent entity. It would be desirable to
capture the global picture of sample clusters within one vi-
sual representation while simultaneously presenting the spe-
cific expression pattern within each individual sample, and
hence, simultaneously allowing gene-specific analysis.
Current representations, such as the widely used heat
maps in two-way hierarchical clustering [22, 23] or coordi-
nate systems in principal component analysis (PCA), mul-
tidimensional scaling (MDS) and their variants [24–26],
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compress the expression profile information of a sample into
a single quantity, such as a scalar value for the distance (dis-
similarity) between the sample, a branch in a dendrogram,
a narrow column in a heat-map, or a point in reduced-
dimensional space. Such aggregate displays discard possi-
bly relevant information immanent in the complex, higher-
order (system-level) genome-wide expression pattern. This
intrinsic but hidden information reflects the collective be-
havior of genes orchestrated by genome-scale gene regu-
latory networks that govern cell behavior [27]. As pathol-
ogy and radiology teach us, the implicit visual cues present
within a complex image (eg, histological section, radiograph)
cannot be reduced to a set of numerical variables without
loss of system-level information content. Thus, it is possible
that some “irreducible” information contained within high-
dimensional gene profiles of patient or experimental samples
may be lost in current clustering and representation meth-
ods.
In the absence of specific questions or hypotheses, it
would therefore be desirable to be able to directly com-
pare microarray results of individual tumor samples with
their complete feature-richness in the same “holistic” way
as pathologists compare histological tumor samples, namely,
based on human gestalt perception [28]. In contrast to histo-
logical patterns, the thousands of expression values in a mi-
croarray measurement are too dense and irregular to be di-
rectly interpreted in a holistic manner. Hence, they must be
presented in a form appropriate for human pattern recog-
nition without discarding the global, higher-order informa-
tion.
Self-organizing maps (SOMs) have the capacity to dis-
play information-rich diagrams. In the case of microarray
data they can present individual samples as an entity and,
at the same time, display high-resolution patterns within the
transcriptome. A self-organizing map is a neural network al-
gorithm for unsupervised machine learning with a strong vi-
sualization capability [29]. In brief, it assigns a set of N input
objects (eg, genes) to a number K (K < N) rectangular or
hexagonal “tiles” (SOM nodes), each of which represents a
cluster of objects (genes), arranged so as to form a coherent
pattern within a two-dimensional “mosaic” (SOM grid). The
patterns arise because the distances between the tiles on the
mosaic are a function of the similarity between the gene clus-
ters that the tiles represent, with most similar clusters being
adjacent to each other in the mosaic.
Early applications of SOMs for visualization of gene ex-
pression profiles emphasized the gene-centered perspective
(clustering of genes) and used each tile to represent one clus-
ter of genes in order to identify gene clusters with interesting
expression patterns or to link them to gene functions [30]. As
in k-means clustering [31], the number of clusters K is cho-
sen in this approach to approximate the number of expected
number of gene clusters, for example, K = 12 on a 3×4 = 12
node grid. Other studies used SOM in the sample-centered
mode to map individual tumor samples onto the SOM grid
and thereby classify tumor samples into a small number of
diagnostic or prognostic groups [32, 33]. In both cases, an
entire experiment consisting of multiple samples (expression
profiles) was represented by one single SOM grid, and the
sample-specific visualization capabilities of SOM were not
explored. In another study, SOMs were used in the gene-
centered mode to analyze lymphoma samples, but the num-
ber of clusters (K = 22 × 14) was much larger than the ex-
pected number of biological clusters. This use of SOM gen-
erated “high-resolution” mosaics, one for each sample in an
experiment. The characteristic SOM mosaics contained co-
herent patterns generated by the colored tiles ordered so as
to reflect the clustered gene expression profile of the indi-
vidual samples [34]. But while this approach used the visual
representation of SOM, it still focused on finding subset of
genes for classifying tumors. In these cases the SOM maps
were used as graphical representation mostly to illustrate a
particular algorithm of analysis, much as dendrograms serve
to give evidence of hierarchical clustering, but are not ac-
tually read by the human eye to obtain specific informa-
tion. Instead, we propose that SOM displays can be specifi-
cally treated as new, complex objects for a next level analysis,
namely, visual gestalt recognition. Thus, we do not use com-
puter algorithm in the sense of “artificial intelligence,” but
more as “intelligence enhancement” for the human brain in
the holistic comparison of the transcriptomes.
To enable such an integrative analysis based on visualiza-
tion of each tumor sample as a unique and complex molec-
ular portrait, we adapted GEDI—a SOM-based tool devel-
oped for visualizing the dynamics of genome-wide gene ex-
pression profiles [35]—to represent “static” microarray sam-
ples as two-dimensional high-resolution SOM mosaics. Us-
ing published gene expression profiles from a large set of lung
tumor samples [5], we offer a first assessment of the use-
fulness of this type of holistic visual analysis of tumor gene
expression profiles. These studies reveal that human gestalt
perception can lead to discovery of novel biological features
without a preconceived hypothesis, and uncover new rela-
tionships between lung tumor subtypes that had previously
escaped the analysis using conventional algorithmic classifi-
cation techniques [5, 36].
MATERIALS AND METHODS
GEDI analysis software
GEDI is a bioinformatics software package that was origi-
nally developed to visualize multiple parallel time courses of
gene expression profiles (or other high-dimensional molec-
ular portraits) experiments [35]. In the currently available
version it uses unsupervised machine learning algorithms
based on SOM [29] to cluster N genes into K “miniclus-
ters” (or metagenes, see below) andmap the results on a two-
dimensional displays, one for each profile.
The SOMs assign similarly behaving genes to the same
clusters k (k = 1, 2, . . . ,K) and place similarly behaving clus-
ters in close vicinity to each other on a two-dimensional,
rectangular SOM grid of a × b nodes, where a × b = K .
Thus, the objects that are being clustered are gene vectors gi =
[x1i , x
2
i , . . . , x
M
i ] (with i = 1, 2, . . . ,N), where x ji represents
the expression value of gene i in sample j (with j =
1, 2, . . . ,M). Once the SOMhave assigned all the genes intoK
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miniclusters, each minicluster is represented by a metagene
vector ck = [y1k , y2k , . . . , yMk ], (k = 1, 2, . . . ,K), where y jk is
the centroid value of minicluster k in sample j. To visualize
one microarray sample j as one mosaic, GEDI slices the clus-
tered data volume consisting of the bundle of the k metagene
vectors ck into slices j across all the K metagenes to create
individual SOM mosaics for each sample j. Each mosaic j
displays in each of its K tiles k the jth component y
j
k of each
metagene vector ck (see Figure S1 in supplementary informa-
tion; available online at DOI 10.1155/JBB/2006/69141). The
value of y
j
k is reflected by the color of the tile. Since the SOMs
arrange the metagenes on the grid based on similarity of be-
havior in the various samples, the K tiles collectively create a
coherent visual pattern for each microarray j. In accordance
with previous usage [12, 35], such SOMmosaics that display
a characteristic visual pattern for each individual expression
profile representing a sample are referred to as “GEDI maps.”
Each corresponding tile k on each GEDI map represents the
same metagene, and hence, the same minicluster of genes.
The original Matlab-based prototype program [35]
was redesigned and rewritten in Java to generate a user-
friendly platform-independent program with improved
performance, stability, and convenient user interface. Results
presented here were obtained with GEDI version 3.0 that
is freely available to members of the academic community
for noncommercial use and can be downloaded via the
web (http://web1.tch.harvard.edu/research/ingber/GEDI/
gedihome.htm). This new program version contains a
series of added functionalities that facilitate comparison
of samples and retrieval of gene-specific information for
individual genes that exhibit interesting patterns. These
functions include real-time navigation through both the
sample and gene dimension to view either a sample or gene
as an individual object. With one mouse click, the name,
functional annotations, and behavior in sample space of
every individual gene can be retrieved directly. The new
version also allows multiple result output formats and
exposes the internal parameters for expert users to optimize
the SOM.
Dataset
Gene expression profile data from normal lung and pul-
monary tumor from the previous work of Bhattacharjee and
coworkers [5] (http://www.broad.mit.edu/mpr/lung) were
used. The data were obtained as Affymetrix array raw image
(DAT) files and analyzed, scaled to a target intensity of 1500
using the microarray suite (MAS) 5.0 program (Affymetrix).
A total of M = 25 samples were used in this analysis, com-
prising 4 different tissues: squamous cell lung carcinoma (Sq,
n = 6), pulmonary carcinoid (Car, n = 6), small-cell lung
carcinoma (SmC, n = 6), and normal lung (Lung, n = 7).
Thus the input data matrix for clustering was (N = 12562)×
(M = 25).
Preprocessing of data
TheN×M datamatrix was log2-transformed to obtain a nor-
mal distribution of the originally log-normally distributed
“signal” values to prevent bias by outlier genes in the cluster-
ing. Each sample was standardized to the z-score to further
minimize global sample-to-sample variability due to external
factors. The resulting value x
j
i for gene i in sample j was used
for further calculations. To avoid bias by explicit selection of
genes that can differentiate between the tissues, we present
here analysis based on the unfiltered list of 12562 genes. Al-
though GEDI performed well without filtering, a prefiltering
step (eg, removing genes that never change significantly in
all samples) in general improved the performance of sample
clustering, as is the case with other clustering algorithms.
Analysis by GEDI and hierarchical clustering
The data was analyzed using the program GEDI [35] (http://
web1.tch.harvard.edu/research/ingber/GEDI/gedihome
.htm) (Version 3.0) and by hierarchical clustering. In the
GEDI analysis, 31× 30 grid configuration of SOM was used,
giving rise to 930 miniclusters. For specific parameters, see
supplementary information. Hierarchical clustering was
performed with the program ClustanGraphics 6.0. (Clustan
Ltd, Edinburgh, Scotland; http://www.clustan.com) [37].
The clustering was performed in the “sample dimension,”
using Euclidean distance as a (dis)similarity measure be-
tween globally normalized samples and the “average linkage”
method to build the dendrogram [37].
Correlation matrix Cgene of size M ×M = 25× 25 is cal-
culated from the original gene expression data matrix of size
N ×M = 12562 × 25. The entry correlation coefficient r jk
between the samples j and k was calculated as
∑N
i=1
(
x
j
i − x j
)(
xki − xk
)
√∑N
i=1
(
x
j
i − x j
)2
√∑N
i=1
(
xki − xk
)2
, (1)
where i is the index of the N gene vectors, x j and xk are the
mean gene expression values of samples j and k, respectively.
Similarly, correlation matrix Cmetagene of size M × M =
25 × 25 is calculated from the metagenes data matrix of size
K ×M = 930× 25 exported from GEDI program.
RESULTS
GEDI analysis of static gene expression profiles
Starting from an N × M matrix of data from the analysis
of N genes across M samples (mRNA expression profiles),
GEDI transforms each sample’s expression profile into a map
that contains a visually recognizable color pattern, referred
to as a “GEDI map” [35]. These maps are mosaics generated
by self-organizing maps (SOMs) (see Materials and Meth-
ods). In brief, this was achieved by (i) a moderate reduction
of dimensionality with respect to the genes, from N genes
into K gene clusters, which are represented by “metagenes,”
and (ii) by a spatial reordering of these metagenes onto a
two-dimensional space represented by an a-by-b grid (with
a × b = K) using SOM [29]. Each mosaic represents the
gene expression profile of a sample [34]. The “expression val-
ues” of the metagenes are the centroids of the corresponding
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Figure 1: Comparison of GEDI maps and hierarchical clustering. Left: dendrogram from hierarchical clustering, computed from 12 562
genes showing 4 main clusters of samples indicated by colors (Lung = normal lung, Sq = squamous cell carcinoma, SmC = small cell lung
cancer, Car = carcinoid). Most samples from the same tissue type (diagnosis) form dense clusters. Note that one outlier, SmC6, did not
cluster together with the other SmC samples. Right: GEDI maps. Three representative samples of each tissue type (diagnosis) are shown. The
outlier sample SmC6 is shown on the right of the other SmC samples.
clusters [30] and are displayed as one of the K colored “tiles”
in the mosaic. Since the SOMs assign the same metagene to
the same tile for each mosaic, they can be compared to each
other. Moreover, since metagenes that exhibit a similar be-
havior with respect to theM samples are placed next or close
to each other on the mosaic, the tiles collectively create a co-
herent pattern on each mosaic that is characteristic for each
sample [29, 38].
Importantly, in contrast to conventional cluster analysis
using k-means or SOM, where typically K < 30 clusters [30],
here K is many folds higher than the expected or desired
number of biologically significant clusters, and hence, each of
the K metagenes can be viewed as representing a “miniclus-
ter” of just a few genes (with a typical median of around 10
genes). A minicluster is thus not meant to represent some bi-
ologically relevant gene cluster. Instead, the SOM algorithm
is used to “pixelate” the expression profile into K pixels and
rearrange them, which is why K is required to be high: typ-
ically, K = 100 s to 1000 s [12, 13]. These miniclusters con-
sequently contain an order of magnitude fewer genes than in
conventional gene clustering [30] and are hence more homo-
geneous, warranting the representation as a metagene. Ac-
cordingly, the patterns formed by the metagenes on a GEDI
map will be referred to as “metapattern.”
Based on the characteristic visual metapatterns, GEDI
maps allow the direct comparison of the biological samples,
as well as immediate identification of biologically interesting
groups of genes.
Visual identification of lung cancer types
The genome-wide gene expression profiles of 25 samples of
normal lung tissue (Lung) and different pulmonary tumors,
carcinoid (Car), squamous cell carcinoma (Sq), and small-
cell cancer (SmC) [5], were visualized as 25 GEDI maps, each
consisting of a 31-by-30 mosaic, representing 930 miniclus-
ters. Discrete differences in patterns of gene expression be-
tween normal lung and tumor samples are immediately de-
tected upon visual inspection of the GEDI maps (Figure 1).
Each sample exhibits characteristic spatial and color patterns,
reflecting genome-wide transcriptional behavior of the re-
spective tissue sample. The visual patterns of the GEDI maps
of these different tissue samples remained distinct when the
analysis was performed with a wide range of SOM parame-
ters and the SOMs were run to convergence (not shown).
Inspection of GEDI maps allows a straightforward clas-
sification of the samples into subgroups without the aid of
a clustering algorithm, but simply based on the visual dif-
ferences in the metapatterns. Samples grouped together with
members of the same category, with the exception of one out-
lier, a small-cell lung cancer sample, SmC6 whose GEDI map
looked different (Figure 1). As previously demonstrated [5],
hierarchical cluster analysis reliably arranged these lung tu-
mor samples into distinct clusters which corresponded well
to the different clusters identified using GEDI (Figure 1).
A known drawback of hierarchical clustering is that the
linear arrangement of the clustered objects (samples) at
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Figure 2: A hierarchical dendrogram computed from the same data as in Figure 1, but with randomly permutated genes. Mixed tissue types
can be seen in the same branches of the tree. On the right, random patterns in GEDI maps from three representative samples of each tissue
type.
the terminal branches of the dendrogram can be presented
in multiple ways (orderings). This can make the unbiased
global assessment of intersample similarity across all the
samples difficult. Although this arbitrariness can be elim-
inated by using a one-dimensional SOM, k-means cluster-
ing, or other optimization algorithm to achieve some objec-
tive branch ordering [39, 40], this method is not often used.
By contrast, because there is no a priori clustering structure
in GEDI, sample clustering is directly obvious and robust
and avoids bias suggestion of relatedness—a known problem
with hierarchical clustering.
Another shortcoming of hierarchical clustering is that the
hierarchical relationship displayed in the dendrograms does
not necessarily have a biological meaning. For example, hi-
erarchical clustering forces the randomly permuted data into
a tree structure with similar overall structure (albeit with a
higher distance score between the branches) even though the
“samples” have now random attributes and have no mean-
ingful relation (Figure 2). In contrast, in this case the GEDI
maps immediately reveal the poor quality of clustering: the
samples that were clustered together by hierarchical cluster-
ing do not exhibit any consistent global pattern (Figure 2).
Therefore, GEDI also provides a first-line sample-centered
quality control for traditional clustering methods.
Because GEDI maps provide a global view of the gene ex-
pression profiles of each sample, they immediately present an
explanation for why a particular sample behaves as an outlier
(when sample diagnosis is known) and which genes account
for that behavior. For example, the dramatic difference be-
tween the GEDI map of an outlier, SmC6 (Figure 1), relative
to samples within the cluster of nominal small-cell lung can-
cers immediately reveals that SmC6 deviates from the other
small-cell carcinomas and the different pattern of tiles ex-
plains why.
Fidelity of GEDI maps in representing
tissue transcriptomes
In addition to visually comparing GEDI maps as individual
entities, one can extract the numerical centroid values y
j
k in
sample j of each metagene k to analyze GEDI maps quanti-
tatively. By utilizing the metagenes instead of the “real” genes
to characterize a transcriptome, the complexity is reduced, in
our case from the original data matrix N ×M = 12562× 25
to 930× 25.
To evaluate the “fidelity” of GEDImosaic patterns in rep-
resenting the expression profiles established by all the genes,
we calculated the correlation coefficients r jk for every pair of
samples ( j, k) using either (1) the expression data for all of
the individual genes or (2) the metagenes. If the GEDI mo-
saic patterns of metagenes faithfully represent the genome-
wide gene expression profiles, the correlation coefficients for
all sample pairs calculated in these two ways will be similar.
In fact, the GEDI patterns preserved the correlation between
samples obtained from the real gene expression data (Figures
3(a), 3(b)). The correlation of the values and the ranks of r jk
between the two methods were 0.909 and 0.960, respectively.
Interestingly, the values of the correlation coefficients
(profile similarity between samples) calculated from meta-
genes spanned a considerably broader range than those from
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Figure 3: Correlation coefficients of samples using simple gene approach or gene pattern approach. (a), (b) Matrix of correlation coefficient
values rjk for the correlation between all pairs of sample j versus k, based on “real” gene expression values (a) or metagene (centroid) values
(b). (c), (d) Histograms of all the correlation coefficient values from (a) (histogram (c)) and (b) (histogram (d)), respectively. (e) Average
correlation of intra-tissues (n = 66) and inter-tissues (n = 234) sample pairs when real gene and metagene data are used, respectively.
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the “real” gene expression dataset, as apparent in the his-
tograms of the correlation values (Figures 3(c), 3(d)). This
is also manifested in the better “color contrast” of the cor-
relation matrix color map (Figure 3(b) versus 3(a)). Thus, it
appears that the discriminating power of this technique us-
ing metagenes may be increased relative to standardmicroar-
ray analysis. The differences in the average correlation be-
tween sample pairs within the same tissue groups (“intratis-
sue pairs”) and across tissue groups (“intertissue pairs”) were
considerably larger when metagenes (0.127, 95% confidence
interval: 0.109 to 0.145) were used for calculating the corre-
lation, compared to when real genes (0.069, 95% confidence
interval: 0.058 to 0.080) are used (Figure 3(e)). It remains
to be determined statistically in extended data sets whether
metagene-based analysis consistently has a greater discrim-
inating power by using larger test sets of tissue samples for
patient groups with established diagnosis.
In summary, the GEDI maps based on metagenes faith-
fully recapitulate gene expression profiles of the entire gene
dataset despite dimension reduction. Thus, the visual pat-
terns capture the real similarity relationships among samples
with a high fidelity.
Second-level GEDI maps
To further validate how well metapatterns can represent the
transcriptome, we applied a “second-level” GEDI analysis
to categorize GEDI maps automatically using the (N =
930 metagenes×M = 25 samples) matrix as input data. For
comparison, we also performed a PCA on the original gene
data matrix (with sample columns as the “objects” and gene
rows as the “attributes”). The second-level GEDI analysis dif-
fered from the first-level GEDI analysis performed on the
(N = 12562 real genes ×M = 25 samples) matrix in that
the objects of clustering were the samples but not genes, and
thus a smaller SOM grid was used. Given the discriminatory
power of the metagenes, using them as input variables may
improve the quality of sample clustering.
The 25 samples were assigned to a 5 × 5 SOM grid ac-
cording to their metagene expression profiles. In the result-
ing second-level GEDImap, the tissue samples (the first-level
GEDI maps) of the same diagnosis were grouped within the
same neighborhood of the map (Figure 4(a)). The map dis-
tances from each tumor-specific sample cluster to that of
normal lung (Lung) were roughly similar, while among the
tumors, the carcinoid (Car) and squamous cell carcinoma
(Sq) samples were most distant from each other, with small-
cell lung cancer (SmC) in between.
Interestingly, the spatial distribution of these samples in
the two-dimensional second-level map was very closely mir-
rored in the PCA in which the samples were projected on
the plane spanned by the two first eigenvectors (Figure 4(b)).
There was good agreement even with respect to the relative
position of the individual samples within each tumor and tis-
sue type (Figure 4(a) versus 4(b)).
Importantly, such information revealed by the 2D sam-
ple plane, be it the SOM grid of the second-level GEDI or
the PCA plane, can be directly read from the metapatterns of
the GEDI maps. Visual inspection of the GEDI maps read-
ily confirms the notion that Sq2 displays significant feature
similarity to the SmC samples based on the fine structure
of the patterns of upregulated genes. Specifically, the GEDI
metapattern showed that Sq2 lacked the extension of the red
areas (highly expressed genes) from the right half into the
upper-left quadrant of the GEDI map that is characteristic
for the other Sq samples (Figure 4). Interestingly, this group
of metagenes that was not expressed in Sq2 contained mul-
tiple keratin-related genes, consistent with the squamous cell
origin of these tumors. Without the GEDI maps, the sam-
ples would be represented by dots in the PCA which would
be identified solely by their position in the abstract eigen-
vector space. Thus, GEDI allows the rapid toggling between
gene-centered and sample-centered perspectives, which is an
important feature for an integrative yet gene-specific analy-
sis.
Qualitative differences between gene profiles
Like small-cell carcinoma, lung carcinoid tumors are also
classified as (low-grade) neuroendocrine tumors [41], while
squamous carcinoma appears to be unrelated to this group.
However, in both hierarchical clustering as well as in PCA,
SmC was closer to Sq than to Car (Figures 1 and 4), which is
consistent with the idea that small-cell lung carcinoma may
have an epithelial origin [42], but competes with the notion
of the common neuroendocrine property of SmC and Car.
To examine this dualism we used GEDI to analyze the rela-
tionship between these three pulmonary tumors and normal
lung to compare not only by how much but also how each of
these tumors qualitatively differed from normal lung tissue
and from each other. The GEDI software environment allows
the user to easily perform algebraic operations on whole mo-
saic patterns based on metagene expression values, and for
instance to calculate “average mosaics” from a group of sam-
ples with the same diagnosis or “difference mosaics” to reveal
differential expression patterns between two samples (or av-
erages of two groups). Here we obtained “GEDI difference
maps” (Figure 5(a)) by subtracting the averaged GEDI maps
of normal lung samples from that of SmC, Car, or Sq, respec-
tively. The red areas in the differencemaps indicate genes that
were upregulated in these tumors compared to normal lung
tissue. The outlined areas on the maps represent four islands
(labeled a, b, c, d in Figure 5(a)) that contain the top 5% dif-
ferentially expressed genes in SmC versus Lung.
These studies revealed that SmC and Sq share a set of
features, representing a number of genes located within re-
gions a–c that are commonly overexpressed in both tu-
mors relative to normal lung. This is consistent with the
vicinity of these two tumors in the dendrogram (Figure 1)
and in the PCA sample plane (Figure 4); it also is in line
with the proposed epithelial origin of small-cell lung can-
cer [42]. The specific genes represented by metagenes of the
islands a–c included growth-related genes (involved in cell
proliferation, cell cycle, DNA replication, etc). Such func-
tional enrichment of genes in the “gene islands” underscores
the biological meaning of pattern features in GEDI maps.
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SmC 6 SmC 3 Sq 2 Sq 12 Sq 6 Sq 10
SmC 2 SmC 5 Sq 8 Sq 4
Car 8 Car 2 SmC 4 SmC 1
Car 10 Car 4 Lung 12
Car 6 Car 12 Lung 16
Lung 8 Lung 2 Lung 10
Lung 4 Lung 6
(a)
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SmC 1
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Sq 6 Sq 4
Sq 8
Car 8
Car 10
Car 6
Car 4
Car 2
Car 12
Lung 2
Lung 12
Lung 10
Lung 8
Lung 4
Lung 6
Lung 16PC1
PC2
(b)
Figure 4: Grouping GEDI maps of different tissue types using a second-level GEDI. (a) The 25 different samples were assigned to a 5 × 5
SOM grid according to their metagene expression profiles using GEDI. The GEDI maps of the individual tissues are shown placed in the
second-level SOM grid. Same types of tissues are grouped in the same neighborhood of the second-level map. (b) Principle component
analysis. Each sample is mapped onto the plane spanned by the two first principal components (PC1 and PC2). Instead of representing a
sample by a symbol, the GEDI map of each sample is shown. Note the similarity in sample position between (a) and (b).
Interestingly, the SmC samples while globally close to Sq
samples, shared with the Car samples the island d, which
contained neuroendocrine-related genes (involved in synap-
tic vesicle, neuromuscular physiological process, etc), consis-
tent with the neuroendocrine nature of small-cell lung carci-
noma [41].
This example illustrates how GEDI can extract relation-
ship features that are not revealed by traditional hierarchical
clustering or any reduction of sample comparisons to a simi-
laritymetric. Specifically, while three islands (a–c) that repre-
sent the regions of metagenes upregulated in SmC compared
to normal lung also were found in Sq (a, b, c), they were ab-
sent from Car. Conversely, the island d that was enriched for
the neuroendocrine genes was overexpressed in Car but not
in Sq. Thus, the GEDI analysis exposed a novel facet of rela-
tionship between the samples with respect to these signature
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(b)
Figure 5: GEDI maps reveal a qualitative aspect in the quantitative
difference between tumor types with respect to expression of promi-
nent marker genes. (a) Difference maps were obtained by element-
wise subtraction of the averagemetagene expression levels, averaged
for all samples in the same diagnosis group of tumor tissues and
normal tissues respectively. The circled regions a–d represent four
“gene islands” containing the 5% most upregulated genes in SmC
compared to normal lung. Color bar represents centroid values after
subtraction. (b) Schematic of the qualitative relationship between 3
types of tumor samples: SmC appears to be the union set of Sq and
Car with respect to the selected genes that are differentially overex-
pressed in SmC relative to normal lung.
gene clusters: SmC appears to be the union set of the sets of
Car and Sq (Figure 5(b)), sharing the gene cluster d with Car
and the clusters a, b, and c with Sq. With respect to these
growth-related gene islands, there was essentially no overlap
between Car and Sq. Thus, despite the overall higher sim-
ilarity between SmC and Sq, when considering the subfea-
ture d with the neuroendocrine genes, SmC was closer to Car
than to Sq. Such information on a qualitative relationship is
lost in conventional clustering dendrograms that reduce re-
lationships to a numerical similarity between two samples
[42]. Without an a priori hypothesis, such qualitative rela-
tionships are almost impossible to identify in the widely used
heat maps, but they immediately spring to eye in the differ-
ential GEDI maps.
DISCUSSION
Genome-scale gene expression profiles are not simply high-
dimensional sets of variables that provide an opportunity
for multivariate statistical analysis. Instead, they are the bi-
ological manifestation of the constrained dynamics of the
underlying complex and hierarchical gene regulatory net-
works that govern developmental potentials of cells and tis-
sues [27]. Tumors arise from mutational rewiring of this
molecular network and therefore, display specific, coordi-
nated deviations from the normal transcriptome patterns.
To visualize coherent, genome-scale alterations of the tran-
scriptome structure, we used here an integrative visual rep-
resentation for gene expression profiles. As a test example
we analyzed expression profiles of three lung tumor sam-
ples as a case study. We show that by delegating the actual
process of pattern recognition to human gestalt perception
in the format of SOM-based GEDI mosaics, interesting fea-
tures in the relationship between tumor types can be re-
vealed. Specifically, we found that with respect to pathologi-
cal deviation from normal gene expression, small-cell carci-
noma represents the union set of squamous cell carcinoma
and carcinoids. Such information on higher-order transcrip-
tome changes, which may be useful for understanding devel-
opmental relationships and differences in drug responsive-
ness between tumor types, spring to eye in the GEDI maps,
but would not have been revealed in conventional algorithms
without explicitly asking the appropriate question.
Microarray-based molecular profiles are increasingly
used to capture characteristic high-dimensional molecular
“portraits” to identify diagnostic and prognostic groups in
cancer. Most existing methods reduce complex relationships
to a numerical value, typically, a distance metric or a visual
distance between points in a reduced dimension space.While
this is useful for explicitly extracting specific information,
these methods may lose potentially useful, unanticipated in-
formation inherent in the high-dimensional expression pro-
files, such as particular higher-order patterns of expression.
Similarly, even the search for a multigene signatures [15] in-
stead of a single marker gene to improve discrimination be-
tween diagnostic groups may miss some of the distributed
(“holistic”) information in the profiles. In fact, maximal ac-
curacy of multiclass tumor classification may require that the
predictor utilizes all the genes [43].
The GEDI visualization software was developed to cir-
cumvent the problem of discarding implicit, potentially ir-
reducible information inherent in genome-wide expression
profiles in the absence of a specific hypothesis. It provides
the opportunity for a holistic, yet molecular exploration of
a set of gene expression profiles (or other high-dimensional
data sets) that can be used to test existing tissue-level biolog-
ical hypotheses [12] or establish new ones. Although GEDI
uses a SOM algorithm at its core, it differs fundamentally
from the traditional use of SOM to find biologically mean-
ingful clusters [30, 32, 33, 38]. The metagenes in GEDI are
miniclusters that are smaller by an order of magnitude than
the explicitly predefined clusters in the conventional cluster
analysis, hence they are very tight and of high quality. The
identification of biological clusters is not the result of the
clustering algorithm per se, but is achieved at a later stage of
analysis, namely, by visual inspection and gestalt perception
of the metapatterns that emerge from the SOM-generated
metagenes. Hence, ambiguities in clustering of samples are
not built into the algorithm, but are subject to direct and in-
teractive analysis by the interpreter.
GEDI provides several technical benefits relative to exist-
ing high-dimensional data analysis methods.
(a) By presenting metapatterns, GEDI maps provide a vi-
sual engram of each sample’s particular molecular profile,
and hence, establish a molecular portrait in the very sense
of the word, with a particular visual identity for each sample
(eg, tumor type, patient, treatment condition).
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(b) Although classification of samples into groups is
achieved by human gestalt perception of the metapatterns,
it can be supported by an algorithmic approach applied on
the metagenes.
(c) The direct visual monitoring of the portrait of a sam-
ple allows GEDI to intercept algorithmic idiosyncrasies, such
as the dependence of the branching structure of dendro-
grams on the particular tree-building algorithm used in hi-
erarchical clustering.
(d) Despite a moderate dimension reduction, GEDI pre-
serves most of the information richness of entire molecu-
lar portraits, allowing detailed, multivariate explorative com-
parisons between samples. This in turn can help define qual-
itative differences (in addition to measuring quantitative dis-
similarity between samples) that may provide additional bi-
ological information on the relationships between samples.
(e) GEDI allows the rapid and seamless switching be-
tween an integrative, sample-oriented analysis and the more
traditional gene-centered analysis. This is facilitated by the
interactive user interface that permits retrieval of genes that
contribute to metapattern features of interest.
(f) Finally, using GEDI to compare the samples and relate
them to each other does not require specific knowledge of the
underlying algorithm, and thus is an intuitive tool for non-
bioinformaticians, such as pathologists and clinicians that
will increasingly confront microarray analysis. This is specifi-
cally relevant for the explanation of anomalies in cluster anal-
ysis, such as outlier samples. The reason for misclassification
is usually directly evident in the GEDI map and does not re-
quire familiarity with the details of the algorithm.
GEDI does not replace, but complements, existing algo-
rithmic clustering methods. Although biologists have begun
to use GEDI maps [12, 13, 44] to ask biological questions,
further systematic elucidation of its application, notably, the
choice of optimal size of miniclusters is needed. Moreover,
it is at the moment not yet optimized for visual discrimina-
tion. Other methods to create the mosaics can be envisioned.
Future use of GEDI in studies of the genome-scale molec-
ular signature of both normal and disease samples will ulti-
mately help assess the true value of a “holistic” interpretation
of molecular profiles that systems biology is advocating.
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